ArticleBMJ open2020

Are patients with stage III non-small cell lung cancer treated with chemoradiotherapy at risk for cardiac events? Results from a retrospective cohort study.

Juliette Degens et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.